Alkindi Sprinkle (hydrocortisone)
Title: Alkindi Sprinkle (hydrocortisone)Category: MedicationsCreated: 10/13/2020 12:00:00 AMLast Editorial Review: 10/13/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 13, 2020 Category: Drugs & Pharmacology Source Type: news
Alkindi Sprinkle (Hydrocortisone Oral Granules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 12, 2020 Category: Drugs & Pharmacology Source Type: news
Class 2 medicines recall: Boots Dermacare 1% w/w Hydrocortisone Ointment
The Boots Company PLC has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling a specific batch of Dermacare 1% w/w Hydrocortisone Ointment as a precautionary m (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 6, 2020 Category: Drugs & Pharmacology Source Type: news
Class 2 medicines recall: Boots Dermacare Hydrocortisone Ointment
The Boots Company PLC has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling a specific batch of Dermacare 1% w/w Hydrocortisone Ointment as a precautionary m (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 6, 2020 Category: Drugs & Pharmacology Source Type: news
FDA Approves Alkindi Sprinkle (hydrocortisone oral granules) for Pediatric Adrenocortical Insufficiency
DEER PARK, Ill., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 30, 2020 Category: Drugs & Pharmacology Source Type: news
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced mortality in hospitalized patients with COVID-19 who required respiratory support. Objective To estimate the association between administration of corticosteroids compared with usual care or placebo and 28-day all-cause mortality. Design, Setting, and Participants Prospective meta-analysis that pooled data from 7 randomized clinical trials that evaluated the efficacy of corticosteroids in 1703 critically ill patients with COVID-19. The trials were con...
Source: Current Awareness Service for Health (CASH) - September 17, 2020 Category: Consumer Health News Source Type: news
Hydrocortisone Early After Septic Shock Onset May Aid Outcomes
THURSDAY, Sept. 17, 2020 -- For patients with vasopressor-dependent septic shock, early hydrocortisone use is associated with improved outcomes, according to a study published online Sept. 2 in SHOCK.
Gretchen L. Sacha, Pharm.D., from the Cleveland... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 17, 2020 Category: Pharmaceuticals Source Type: news
Prevention of Adrenal Crisis Prevention of Adrenal Crisis
What is the most appropriate hydrocortisone dose and delivery mode to prevent adrenal crisis among patients with adrenal insufficiency?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 17, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Corticosteroids in the treatment of suspected or confirmed COVID-19 , Chief Medical Officer
Following recent publication of the REMAP-CAP trial for hydrocortisone and a meta-analysis of corticosteroids, the WHO has recently issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 4, 2020 Category: Consumer Health News Source Type: news
Widely-used and cheap steroid hydrocortisone can cut coronavirus deaths by a THIRD
An analysis by University of Bristol of seven different studies found three steroids reduce the risk of death in critically ill Covid-19 patients by 20%, which bumped up to 31% for hydrocortisone. (Source: the Mail online | Health)
Source: the Mail online | Health - September 3, 2020 Category: Consumer Health News Source Type: news
